VDR and neoplasm: Previously, we demonstrated that restoring the quiescent state of PSCs, by replenishing their physiological retinol depots using the pleiotropic agent all‐trans retinoic acid (ATRA), halted tumour progression through targeting multiple tumour–stromal signalling cascades 13, 14, a notion recently supported by targeting the vitamin D receptor 15.